Journey Advisory Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Journey Advisory Group's AMGN Position: Q2 2026 in Review
Journey Advisory Group increased its Amgen (AMGN) stake by 2% in Q2 2026, buying an estimated $42.4K and bringing the position to 6,427 shares worth $2.33M. The position accounts for 0.18% of the portfolio, ranked #116.
Journey Advisory Group first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.17M in Q4 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Journey Advisory Group held 6,427 shares of Amgen worth $2.33M as of Q2 2026.
- Journey Advisory Group bought 124 Amgen shares in Q2 2026, an estimated $42.4K.
- Amgen made up 0.18% of Journey Advisory Group's portfolio in Q2 2026, its #116 holding.
- Journey Advisory Group first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- Journey Advisory Group's Amgen position peaked at $8.17M in Q4 2024.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.